Full-Time

Key Account Manager Rare Diseases

Confirmed live in the last 24 hours

Takeda

Takeda

10,001+ employees

Global biopharmaceutical firm focused on R&D

No salary listed

Senior

Italy

Preferred residence includes regions such as Piemonte (Torino or Southern Region), Emilia Romagna (Bologna), Toscana (Firenze), Campania, Puglia, and others.

Category
Strategic Account Management
Sales & Account Management
Requirements
  • Scientific University Degree qualification according to art. 122 of D.Lgs. 219/2006 or being employed as Medical Rep with a date prior to 6 July 2006
  • Good written and spoken English is mandatory (at least B2)
  • Solid experience in promoting pharmaceutical products with high demand of clinical explanation and a proven track of records
  • Good knowledge of local KOLs as preferred
  • Ability to plan start and control projects using core project management principles and tools
  • Knowledge of the Italian health care systems
Responsibilities
  • Implement Rare Business Unit plan within own territory, consistently with Business Unit objectives, guidelines and in compliance with local regulations
  • Drive the commercial execution for Rare Diseases Therapies with a focus on several specialists
  • Deeply understand own therapeutic areas, including the strengths and weaknesses of competing products
  • Schedule own business activities consistently with BU objectives, preparing/scheduling interviews / meetings and recording the relevant information collected
  • Provide daily/monthly reports to the line manager in relation to the performance of relevant area and the changes taking place
  • Implement promotional activities for company's products, in terms of projects, events, conferences, etc., within budget constraints
  • Develop relationship and partnership with Key Opinion Leaders at local and domestic level
  • Develop, sustain and grow highly effective working relationships with key medical institutions, medical and academic societies
  • Identify, develop and foster professional long lasting peer-to-peer relationships with key physicians, key opinion leaders (KOL) and academic centres
  • Comply with the company Compliance Guidelines, Code of Conduct and Promotional Practices
  • Serve as a direct liaison to the Rare Diseases team by providing marketplace intelligence/insights
  • Define, in partnership with line manager, plans for accounts that flow logically from analysis to strategy to tactics
Desired Qualifications
  • Previous experience in Rare Diseases or Plasma Derived Therapies is a plus
  • Good knowledge of local KOLs as preferred

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines. The company invests heavily in research and development to create new molecular entities (NMEs) and has a pipeline of 11 NMEs, aiming for up to 15 product launches by FY2024. Takeda's products are designed to meet the needs of healthcare providers, hospitals, and patients around the world. What sets Takeda apart from its competitors is its strong commitment to patient-centric values and environmental sustainability, recognizing the connection between human health and environmental health. The company's goal is to innovate and provide life-changing therapies while ensuring that patient needs are prioritized.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's focus on personalized medicine can increase treatment efficacy and patient satisfaction.
  • Expansion in Southeast Asia offers opportunities for increased market presence and revenue growth.
  • Collaborations with tech companies can accelerate R&D processes and reduce costs.

What critics are saying

  • Data breach could lead to financial and reputational damage for Takeda.
  • Antitrust litigation with Meijer may result in financial penalties or business practice changes.
  • High financial commitments in partnerships could strain resources if outcomes are not achieved.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations and R&D efforts.
  • Takeda's robust pipeline includes 11 NMEs with plans for 15 product launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

CyberNews
Apr 15th, 2025
Hackers want $75,000 for data allegedly stolen from Takeda

A new account on an illicit forum bearing the moniker "beltway" claims that in April 2025, it exported around two million rows of user information from Takeda.com.

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.

Pharmaceutical Technology
Feb 25th, 2025
Takeda broadens its deal with BridGene for up to $770m

Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology.